Literature DB >> 17360790

Liver disease in erythropoietic protoporphyria: insights and implications for management.

A V Anstey1, R J Hift.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17360790      PMCID： PMC1994365          DOI： 10.1136/gut.2006.097576

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  113 in total

Review 1.  Erythropoietic protoporphyria: clinical aspects with emphasis on the skin.

Authors:  H Baart de la Faille; J C Bijlmer-Iest; J van Hattum; J Koningsberger; L H Rademakers; H van Weelden
Journal:  Curr Probl Dermatol       Date:  1991

2.  Ferrochelatase activities in patients with erythropoietic protoporphyria and their families.

Authors:  G Goerz; S Bunselmeyer; K Bolsen; N Y Schürer
Journal:  Br J Dermatol       Date:  1996-05       Impact factor: 9.302

3.  Liver failure in erythropoietic protoporphyria associated with choledocholithiasis and severe post-transplantation polyneuropathy.

Authors:  G Lock; A Holstege; A R Mueller; W Christe; M O Doss; J Schölmerich; P Neuhaus
Journal:  Liver       Date:  1996-06

4.  Recovery from hepatic decompensation in protoporphyria.

Authors:  C L Conley; J J Chisholm
Journal:  Johns Hopkins Med J       Date:  1979-12

5.  Blood exchange and transfusion therapy for acute cholestasis in protoporphyria.

Authors:  H J van Wijk; J van Hattum; H Baart de la Faille; J W van den Berg; A Edixhoven-Bosdijk; J H Wilson
Journal:  Dig Dis Sci       Date:  1988-12       Impact factor: 3.199

6.  Hepatic complications of erythropoietic protoporphyria.

Authors:  R P Sarkany; P G Norris
Journal:  Br J Dermatol       Date:  1994-02       Impact factor: 9.302

Review 7.  [Severe liver failure in erythropoietic protoporphyria. A report of a case treated by liver transplantation].

Authors:  M Jiménez-Sáenz; A Caunedo-Alvarez; M Rojas; M Mata; J L Villar; A Piñar; J Herrerías-Gutiérrez
Journal:  Med Clin (Barc)       Date:  1999-07-10       Impact factor: 1.725

8.  Ferrochelatase consisting of wild-type and mutated subunits from patients with a dominant-inherited disease, erythropoietic protoporphyria, is an active but unstable dimer.

Authors:  Yoshiko Ohgari; Mari Sawamoto; Masayoshi Yamamoto; Hirao Kohno; Shigeru Taketani
Journal:  Hum Mol Genet       Date:  2004-12-01       Impact factor: 6.150

9.  Erythropoietic protoporphyria in the house mouse. A recessive inherited ferrochelatase deficiency with anemia, photosensitivity, and liver disease.

Authors:  S Tutois; X Montagutelli; V Da Silva; H Jouault; P Rouyer-Fessard; K Leroy-Viard; J L Guénet; Y Nordmann; Y Beuzard; J C Deybach
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

10.  Effect of bile acid hydroxylation on biliary protoporphyrin excretion in rat liver.

Authors:  M M Berenson; J J Garcia Marin; C Gunther
Journal:  Am J Physiol       Date:  1988-09
View more
  27 in total

1.  Chronic Treatment with Isoniazid Causes Protoporphyrin IX Accumulation in Mouse Liver.

Authors:  Madhav Sachar; Feng Li; Ke Liu; Pengcheng Wang; Jie Lu; Xiaochao Ma
Journal:  Chem Res Toxicol       Date:  2016-08-02       Impact factor: 3.739

2.  Treatment options in acute porphyria, porphyria cutanea tarda, and erythropoietic protoporphyria.

Authors:  Pauline Harper; Staffan Wahlin
Journal:  Curr Treat Options Gastroenterol       Date:  2007-12

3.  Afamelanotide for Erythropoietic Protoporphyria.

Authors:  Janneke G Langendonk; Manisha Balwani; Karl E Anderson; Herbert L Bonkovsky; Alexander V Anstey; D Montgomery Bissell; Joseph Bloomer; Chris Edwards; Norbert J Neumann; Charles Parker; John D Phillips; Henry W Lim; Iltefat Hamzavi; Jean-Charles Deybach; Raili Kauppinen; Lesley E Rhodes; Jorge Frank; Gillian M Murphy; Francois P J Karstens; Eric J G Sijbrands; Felix W M de Rooij; Mark Lebwohl; Hetanshi Naik; Colin R Goding; J H Paul Wilson; Robert J Desnick
Journal:  N Engl J Med       Date:  2015-07-02       Impact factor: 91.245

Review 4.  Liver disease and erythropoietic protoporphyria: a concise review.

Authors:  María José Casanova-González; María Trapero-Marugán; E Anthony Jones; Ricardo Moreno-Otero
Journal:  World J Gastroenterol       Date:  2010-09-28       Impact factor: 5.742

5.  Liver metabolomics in a mouse model of erythropoietic protoporphyria.

Authors:  Pengcheng Wang; Madhav Sachar; Grace L Guo; Amina I Shehu; Jie Lu; Xiao-Bo Zhong; Xiaochao Ma
Journal:  Biochem Pharmacol       Date:  2018-06-12       Impact factor: 5.858

Review 6.  Erythroid heme biosynthesis and its disorders.

Authors:  Harry A Dailey; Peter N Meissner
Journal:  Cold Spring Harb Perspect Med       Date:  2013-04-01       Impact factor: 6.915

7.  Role of ABCG2 in liver injury associated with erythropoietic protoporphyria.

Authors:  Madhav Sachar; Xiaochao Ma
Journal:  Hepatology       Date:  2015-10-30       Impact factor: 17.425

8.  Ferrochelatase π-helix: Implications from examining the role of the conserved π-helix glutamates in porphyrin metalation and product release.

Authors:  Mallory E Gillam; Gregory A Hunter; Gloria C Ferreira
Journal:  Arch Biochem Biophys       Date:  2018-02-23       Impact factor: 4.013

9.  A metabolomic perspective of griseofulvin-induced liver injury in mice.

Authors:  Ke Liu; Jiong Yan; Madhav Sachar; Xinju Zhang; Ming Guan; Wen Xie; Xiaochao Ma
Journal:  Biochem Pharmacol       Date:  2015-09-05       Impact factor: 5.858

Review 10.  Erythropoietic protoporphyria.

Authors:  Mario Lecha; Hervé Puy; Jean-Charles Deybach
Journal:  Orphanet J Rare Dis       Date:  2009-09-10       Impact factor: 4.123
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.